Sunshine Lake Pharma Co., Ltd. (HKG:6887)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
40.50
+0.02 (0.05%)
Oct 22, 2026, 4:08 PM HKT

Sunshine Lake Pharma Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-284.91272.44-207.431,99376.6-587.65
Depreciation & Amortization
478.13461.93418.04391.27377.36259.82
Loss (Gain) From Sale of Assets
3.083.08-18.140.530.8219.07
Asset Writedown & Restructuring Costs
67.867.868.31485.39288.8425.98
Loss (Gain) From Sale of Investments
16.716.7-6.32-4.39-522.7-19.24
Loss (Gain) on Equity Investments
-0.25-0.25-0.6-0.22--
Stock-Based Compensation
258.67258.67266.5545.14--
Other Operating Activities
-134.24238.15274.89165.311,084136.21
Change in Accounts Receivable
-121.13-121.131.44-1,418-530.59-216.1
Change in Inventory
-87.82-87.82-208.84-94.02-35.3398.57
Change in Accounts Payable
45.645.6-87.35109.49961.31-379.18
Operating Cash Flow
241.631,155500.531,6731,700-662.51
Operating Cash Flow Growth
-44.69%130.79%-70.09%-1.57%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-138.36-836.04-1,062-343.72-570.07-356.29
Sale of Property, Plant & Equipment
2.321.8361.28-0.950.03
Cash Acquisitions
-15.58-----
Sale (Purchase) of Intangibles
-123-84.73-163.3-251.36-283-223.4
Investment in Securities
-31.89-13.58-11.072,579-290-
Other Investing Activities
315.3449.061,205-1,43021.95140.55
Investing Cash Flow
8.79-483.4529.79554.57-1,120-439.11

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-2,6753,4802,164517.94444.96
Long-Term Debt Repaid
--2,503-4,306-3,454-1,146-157.68
Lease Payments
-501.24-460.02-514.01-150.42-12.5-
Total Debt Repaid
-2,575-2,503-4,306-3,454-1,146-157.68
Net Debt Issued (Repaid)
1,002172.73-825.69-1,290-628.22287.28
Repurchase of Common Stock
-27.12-19.18----
Common Dividends Paid
-584.43-584.43----
Other Financing Activities
-198.15-234.79-144.98-186.63-158.8-99.8
Financing Cash Flow
191.87-665.67-970.67-1,477-787.03187.48

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.15-0.080.99-0.01-0.30.29
Net Cash Flow
442.135.99-439.35750.87-207.58-913.85

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
103.27319.14-561.371,3291,130-1,019
Free Cash Flow Growth
---17.67%--
Free Cash Flow Margin
2.61%6.63%-13.97%21.12%30.17%-111.49%
Free Cash Flow Per Share
0.190.64-1.275.734.87-4.39
Levered Free Cash Flow
879.27650.05982.841,067-2,703-616.5
Unlevered Free Cash Flow
1,018793.931,1331,209-2,527-464.12
Free Cash Flow After Leases
-397.98-140.88-1,0751,1791,117-1,019

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
187.61226.73111.68138.32112.7499.8
Cash Income Tax Paid
200.52120.33247.64230.49255.43-18.62
Change in Working Capital
-163.35-163.35-294.76-1,402395.39-496.71